Related Experiment Videos
Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase
E Kyle1, L Neckers, C Takimoto
1Clinical Pharmacology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Molecular Pharmacology
|February 1, 1997
Summary
Genistein from soy does not inhibit prostate cancer (PCa) growth at dietary levels. However, it may act as a therapeutic agent by inducing apoptosis in PCa cells.
Area of Science:
- Biochemistry
- Oncology
- Molecular Biology
Background:
- Genistein, an isoflavonoid in soy, is linked to lower prostate cancer (PCa) incidence.
- Genistein's potential role in PCa is debated, with proposed mechanisms including cell adhesion and direct growth inhibition.
Purpose of the Study:
- To investigate the in vivo growth inhibitory effects of genistein on PCa.
- To determine if genistein's effects are relevant at dietary consumption levels and understand its molecular mechanisms.
Main Methods:
- Assessed genistein's growth inhibitory activity across various PCa cell lines.
- Conducted mechanistic studies on PC3-M cells, examining effects independent of estrogenic activity and on both adherent and nonadherent cells.
- Measured focal adhesion kinase activity and apoptosis induction.
Main Results:
- Genistein's growth inhibitory effects were observed only at concentrations significantly higher than those achieved through diet.
- Growth inhibition was independent of genistein's estrogenic effects and occurred in nonadherent cells.
- Specific suppression of focal adhesion kinase activity preceded apoptosis induction in adherent PCa cells.
Conclusions:
- Dietary genistein intake is unlikely to significantly inhibit prostate cancer growth in vivo.
- Genistein shows potential as a therapeutic agent for PCa and a tool for studying apoptosis control.